Status: Not yet recruiting
A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections
The objective of this study is to determine whether continuous infusion of ceftazidime-avibactam (CAZ-AVI) could improve clinical outcomes in critically ill patients compared with intermittent infusion.
Participants needed: 1,200
Trial details
Phase: Phase 4Age: 18-85Biological sex: AllType: InterventionalSponsor: Southeast University, ChinaUpdated: Apr 23, 2025
Eligibility criteria
18-85 years old, male or female. [+3]
Patient has a known allergy to ceftazidime-avibactam. [+6]